Literature DB >> 27138764

The Roles of Sox Family Genes in Sarcoma.

Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek, Zhenfeng Duan1.   

Abstract

Sox (SRY-related HMG-box) family genes are important regulators of cell development, homeostasis, and regeneration. Deregulation of certain members of the Sox gene family has been implicated in a number of human malignancies, including in sarcoma. Accumulating evidence suggests that Sox genes play crucial roles in sarcoma cell pathogenesis, growth, and proliferation. Here, we review the biological relevance of Sox2 and Sox9 genes in osteosarcoma, chondrosarcoma and chordoma; Sox2, Sox6, and Sox17 genes in Ewing's sarcoma; Sox2, Sox9, and Sox10 genes in synovial sarcoma; Sox2 gene in fibrosarcoma; and Sox21 gene in liposarcoma. These findings potentiate the targeting of Sox genes for novel therapeutic interventions in sarcoma and may also hold valuable clinical potential to improve the care of patients with sarcoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27138764     DOI: 10.2174/1389450117666160502145311

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  11 in total

1.  Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.

Authors:  Amy B Hont; C Russell Cruz; Robert Ulrey; Barbara O'Brien; Maja Stanojevic; Anushree Datar; Shuroug Albihani; Devin Saunders; Ryo Hanajiri; Karuna Panchapakesan; Sam Darko; Payal Banerjee; Maria Fernanda Fortiz; Fahmida Hoq; Haili Lang; Yunfei Wang; Patrick J Hanley; Jeffrey S Dome; Catherine M Bollard; Holly J Meany
Journal:  J Clin Oncol       Date:  2019-07-29       Impact factor: 44.544

2.  Pluripotency Stemness and Cancer: More Questions than Answers.

Authors:  Jiří Hatina; Michaela Kripnerová; Zbyněk Houdek; Martin Pešta; Filip Tichánek
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  LINC02738 Participates in the Development of Kidney Cancer Through the miR-20b/Sox4 Axis.

Authors:  Chao Han; Bin Xu; Lin Zhou; Long Li; Chao Lu; Guo-Peng Yu; Yu-Shan Liu
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

Review 4.  Aberrant DNA methylations in chondrosarcoma.

Authors:  Pei Liu; Jacson K Shen; Jianzhong Xu; Carol A Trahan; Francis J Hornicek; Zhenfeng Duan
Journal:  Epigenomics       Date:  2016-09-30       Impact factor: 4.778

5.  Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.

Authors:  Liang Tang; Dong Wang; Dongyun Gu
Journal:  Pathol Oncol Res       Date:  2018-04-04       Impact factor: 3.201

6.  SIX1 represses senescence and promotes SOX2-mediated cellular plasticity during tumorigenesis.

Authors:  Cristina De Lope; Samara Martín-Alonso; Jaione Auzmendi-Iriarte; Carmen Escudero; Isabel Mulet; Javier Larrasa-Alonso; Irene López-Antona; Ander Matheu; Ignacio Palmero
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

7.  SOX14 hypermethylation as a tumour biomarker in cervical cancer.

Authors:  Jing Zhao; Huiling Cao; Wenfan Zhang; Yongjuan Fan; Shujuan Shi; Rong Wang
Journal:  BMC Cancer       Date:  2021-06-07       Impact factor: 4.430

8.  Identification of prognostic alternative splicing events in sarcoma.

Authors:  Hongshuai Li; Jie Yang; Guohui Yang; Jia Ren; Yu Meng; Peiyi Qi; Nan Wang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

9.  SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications.

Authors:  Sofia T Menendez; Veronica Rey; Lucia Martinez-Cruzado; M Victoria Gonzalez; Alvaro Morales-Molina; Laura Santos; Verónica Blanco; Carlos Alvarez; Oscar Estupiñan; Eva Allonca; Juan Pablo Rodrigo; Javier García-Castro; Juana Maria Garcia-Pedrero; Rene Rodriguez
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

Review 10.  Biological Heterogeneity of Chondrosarcoma: From (Epi) Genetics through Stemness and Deregulated Signaling to Immunophenotype.

Authors:  Agnieszka Zając; Sylwia K Król; Piotr Rutkowski; Anna M Czarnecka
Journal:  Cancers (Basel)       Date:  2021-03-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.